Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the concept of the exenatide test for diagnosis of EHH (earlier
induction of symptomatic hypoglycemia compared to placebo within 4 hours after injection).